Vol. 283, Issue 6, G1276-G1281, December 2002
Baclofen blocks LES relaxation and crural
diaphragm inhibition by esophageal and gastric distension in
cats
Jianmin
Liu,
Nonko
Pehlivanov, and
Ravinder
K.
Mittal
Division of Gastroenterology, San Diego Veterans Affairs
Medical Center and University of California San Diego, San Diego,
California 92161
Esophageal distension and transient
lower esophageal sphincter (LES) relaxation (TLESR) are accompanied by
simultaneous relaxation of the LES and inhibition of crural diaphragm.
Recent studies indicate that baclofen decreases the frequency of TLESR;
however, its effect on the crural diaphragm is not known. We evaluated the effects of baclofen on LES relaxation and crural diaphragm inhibition induced by gastric distension and esophageal distension in
cats. Five adult cats underwent surgical implantation of wire electrodes into the crural and costal diaphragm for measurement of
their EMG activity, respectively. One week after the surgery, animals
were lightly sedated and recordings were performed using a manometry
catheter equipped with a 2.5-cm balloon. The effects of baclofen (10 µmol/kg iv) on the graded esophageal distension and gastric
distension-induced LES and crural diaphragm responses were studied.
Distension of the esophagus and stomach induces relaxation of the LES
and inhibition of the crural diaphragm, simultaneously. Baclofen blocks
both the esophageal and the gastric distension-induced relaxation of
the LES and inhibition of the crural diaphragm. The magnitude of
response to baclofen was significantly larger for the crural diaphragm
inhibition than for the LES relaxation. Baclofen, a GABAB
receptor agonist, blocks the reflex inhibitory pathway to the LES and
crural diaphragm. The reflex inhibitory pathway to the crural diaphragm
is more sensitive to blockade by baclofen than the reflex LES
inhibitory pathway.
transient lower esophageal sphincter relaxation; gastroesophageal
reflux; crural diaphragm; GABAB agonist